Rationale: Carney complex (CNC) is a multiple neoplasia syndrome with autosomal dominant inheritance. CNC is characterized by the presence of myxomas, spotty skin pigmentation, and endocrine overactivity. No direct correlation has been established between disease-causing mutations and phenotype.
Introduction
Carney complex (CNC) is a multiple neoplasia syndrome with an autosomal dominant inheritance. [1] The clinical manifestations of CNC vary widely but may include myxomas of the heart, skin, and other tissues and multiple other endocrine and nonendocrine neoplasms including pituitary tumors, adrenocortical tumors, thyroid neoplasms, psammomatous melanotic schwannomas, testicular tumors, breast tumors, ovarian lesions, and bone lesions. [2] More than 80% of CNC patients develop spotty skin pigmentation or skin growths, which typically appear early in life and may be located anywhere on the body, typically on the face, lips, genital area, and mucosa. [3] The most common noncutaneous lesions found in CNC are cardiac myxomas (affecting 20-40% of patients), which are responsible for >50% of CNC-related mortality. [4] [5] [6] CNC is a genetically heterogeneous disease, with >70% patients with CNC carrying mutations of the PRKAR1A gene, [5] which encodes the 1-a regulatory subunit (RIa) of the cAMPdependent protein kinase A (PKA) and functions as a tumor suppressor gene. [7] Pathogenic PRKAR1A mutations include single base substitutions, small (15 bp) deletions/insertions, combined rearrangements, and large deletions. [8] [9] [10] More than 125 PRKAR1A gene mutations have been identified; however, linking genotype to phenotype has been challenging. [11] Although previous studies [5, 9, 10, [12] [13] [14] [15] have demonstrated associations between specific mutations and CNC manifestations, only 3 pathogenic variants (c.82C>T, c.491_492delTG, and c.709-2_709-7 delATTTTT) have been identified in >3 unrelated pedigrees. [5, 7, 13] The other mutations are unique (present in a single kindred). To better understand genotype-phenotype relationships in this rare heterogeneous disease, it is essential to describe clinical features associated with specific mutations.
Here we present a case of CNC with a known germline PRKAR1A nonsense mutation (c.205C>T) [5] ; however, the phenotype associated with this mutation has not yet been established. Our results indicate that this PRKAR1A mutation may be associated with increased pigmentation on the face, lip, and sclera; osteoporosis resulting in compression fracture; and primary pigmented nodular adrenal disease (PPNAD)-associated Cushing syndrome.
Case report
A 16-year-old boy was admitted to our department because of excessive weight gain for 3 years and purple striate for 1 year. His weight was 60 kg, and height was 1.2 m. Physical examination revealed typical Cushingoid features (moon face, buffalo hump, central obesity, and purple striae of the bilateral axilla and lower abdomen) (Fig. 1A) , and spotty skin pigmentation on the face, lip, and sclera ( Fig. 1C-E) . Laboratory findings revealed hypercortisolism (Table 1) . After low-and high-dose dexamethasone suppression tests, cortisol levels were still high (462.9 and 828.3 Fig. 2A and B) . Ultrasonography showed a normal thyroid but multiple microcalcifications of the bilateral testes ( Fig. 2C and D) , suggesting large-cell calcifying Sertoli cell tumor (LCCST). Considering the young age and the will of the patient, the needle biopsy of the testes was not conducted to confirm the LCCST. However, testicular ultrasound is conducted every 6 month to monitor the lesions. Results of magnetic resonance imaging showed a pituitary normal but a compression fracture of the thoracolumbar spine (T5-T12 and L1). Echocardiography did not reveal any cardiac myxomas.
On February 19, 2017, the patient underwent right adrenalectomy via retroperitoneal laparoscopy; however, cortisol levels did not normalize (Table 1) . On March 1, 2017, the patient underwent partial adrenalectomy of the left adrenal gland. Histopathology findings of multiple pigmented nodules substantiated the diagnosis of PPNAD (Fig. 2E) . After the second adrenalectomy, the Cushingoid features disappeared (Fig. 1B) , and cortisol levels returned to normal (Table 1) .
Genetic analysis
Peripheral blood was collected after obtaining informed consent from the patient's grandparents. DNA was extracted from leukocytes and amplified by the polymerase chain reaction.
Bidirectional DNA sequence analysis of the PRKAR1A gene identified a known CNC-causing germline mutation (c.205C>T) in exon 3 (Fig. 2F ) and a second mutation (c.34 G>T) in the intron preceding exon 9.
Discussion
In this study, we describe a patient with patient typical features of CNC such as spotty skin pigmentation on the face, lip, and sclera; osteoporosis resulting in compression fracture; and PPNADassociated Cushing syndrome. DNA sequencing identified a known pathogenic mutation of PRKAR1A. Taken together, our patient met the criteria for the diagnosis of CNC [2] : (1) spotty pigmentation with the typical distribution (face, lip, and sclera); (2) osteoporotic bone changes due primarily to glucocorticoid excess, which accelerates bone resorption and decreases intestinal calcium absorption and bone formation [16] (3); probable LCCST, as demonstrated by ultrasonography of the bilateral testes, which revealed multiple microcalcifications; and (4) Cushing syndrome, which may be ACTH-dependent or ACTH-independent (e.g., caused by PPNAD, as in our patient).
CNC has diverse clinical manifestations, which typically develop over a period of years. [2] Mutations in PRKAR1A appear to be the most common cause of CNC. Patients carrying PRKAR1A mutations have more severe disease, with earlier presentation and higher frequency of myxomas, thyroid, and gonadal tumors, schwannomas, and lentigines compared withPRKAR1A-negative patients. [5, 17] In a small number of PRKAR1A missense mutations, the mRNA escapes nonsense-mediated decay, and the R I-a mutant proteins are associated with a more severe phenotype. [14, 15] Two PRKAR1A mutations (c.709-7del6 and M1V c.1A>G/p.M1V substitution) are associated with low penetrance, early-life isolated PPNAD, and Cushing syndrome. [18, 19] However, in most cases, genotype cannot predict phenotype or penetrance. Therefore, it is necessary to describe clinical features associated with specific mutations. According to our case presentation, the mutation (c. 205 C>T) in our case is inclined to cause pigmented spots, osteoporosis, as well as PPNAD.
In conclusion, we have identified a reported PRKAR1A nonsense mutation (c.205C>T) in a sporadic case of CNC characterized by the spotty skin pigmentation, osteoporosis resulting in compression fracture, and PPNAD-associated Cushing syndrome. The description of clinical features of this patient adds to our knowledge of CNC and PRKAR1A mutations. The ability to recognize CNC is important for early diagnosis and prevention of severe complications. PRKAR1A mutation analysis should be conducted as soon as possible in patients with suspected CNC.
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